section-00087c8

PIONEERING AS A PHARMACEUTICAL SUPPLIER OF MEDICINAL CANNABIS 01. Providing for Today About Us STATE OF THE ART CULTIVATION AND ADVANCED GENETIC STRAINS 02. Innovations About Us
section-2d62d7f
Products

Both Botanical and oil-based wholesale pharmaceutical product offerings

GMP & GACP Certification

Fully accredited Good Manufacturing Practice and GACP cultivation processes

Executive Team

Senior Executive Leadership Team and Founders

section-cabe089

CINV Corp

About Us

At CINV Corp we plan to become world leaders in the production of medicinal cannabis. We intend to supply extracts and product such as GMP-Flower, GMP-Oil to the pharmaceutical industry as an API (Active Pharmaceutical Ingredient) to meet the increasing global demand for a high specification medicinal cannabis product and transform lives.

We are based in the heart of London with rapidly expanding production operations in Africa.

//www.cinvcorp.com/wp-content/uploads/2020/10/jp-doran-eco-equity-CEO-1.png
JP Doran //www.cinvcorp.com/wp-content/uploads/2019/08/signature.png
section-78ec34f
section-78ec34f

Our Mission

We are passionate about the scientific evidence that proves the potential of medicinal cannabis and we will provide a highly effective API to the pharmaceutical industry for global distribution.

With agreements already in place to supply in the future a GACP & EU-GMP certified medicinal cannabis product via our cultivation facility in Africa that will include R&D facilities and an active breeding programme to create proprietary genetic variants of medicinal cannabis.

section-8a582da
section-8a582da

Our Background

We are the first company to hold a medicinal cannabis licence in Zimbabwe.

With our connections and local trust, we feel we have a growing social responsibility to be a part of rebuilding the Zimbabwean economy, you can read more about Our Job Creation and Community Outreach Programs here.

section-11b5ef4
section-11b5ef4

Contact Us

CINV Corp focuses on export to global regions with a heavy destination focus on Europe which is predicted to be the world’s biggest over the next 10 years. According to Prohibition Partners – Europe’s cannabis market is estimated to be worth up to €123 billion by 2028. CINV Corp intends, through first-mover advantage to become the biggest producer of CBD oil in Southern Africa.

To learn more about how to invest, please visit our investment fund-vehicle, JPD Capital.

section-17f7997

FAQ & Information

Get in touch with us here and a member of our team will get back to you within 24 hours.

To stay up to date with all things CINV Corp, including company progress, exciting new clinical discoveries and our latest blogs sent straight to your inbox, follow our social platforms:

For comment, interviews and other press & media related enquiries please contact our PR team at [email protected]

Do you require medicinal cannabis for yourself or a child? You can learn more about how we can support you via the CINV Corp Foundation here

section-c98d27b

Global Distribution Forecast

15,470

Kg

EU-GMP cannabis flower

1,591

Kg

EU-GMP Oil

6

Strains

In Cultivation
section-5c05d9b

Latest News

Our Blog

The Current Outlook on Cannabis IPO, with Robert Jappie

Robert Jappie is a lawyer and partner at Ince Gordon Dadds LLP, specialising in Life Sciences and Cannabis Regulation for the UK and Europe. CINV Corp is a cannabis company that will soon list on the stock market, we ask his expert opinion on the pros and cons of a traditional .

Acquired licenses to supply the global demand of an effective form of medicinal cannabis to the pharmaceutical industry.